The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Radiation Oncology-Global Market Insights and Sales Trends 2024

Radiation Oncology-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1833204

No of Pages : 104

Synopsis

The global Radiation Oncology market size is expected to reach US$ 7830.8 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Radiation Oncology in various end use industries.

The expanding demands from the Blood Cancer (Leukaemia), Breast Cancer, Gastrointestinal Cancer and Respiratory/Lung Cancer, are propelling Radiation Oncology market. External Beam Radiation Therapy (EBRT), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Brachytherapy segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Radiation Oncology market, driven by demand from China, the second largest economy with some signs of stabilising, the Radiation Oncology market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Radiation Oncology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Radiation Oncology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Radiation Oncology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Radiation Oncology sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Radiation Oncology covered in this report include Accuray, C. R. Bard, Elekta, IBA Worldwide, Varian Medical Systems, Carl Zeiss Meditec, iCAD, IsoRay and Mevion Medical Systems, etc.

The global Radiation Oncology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Accuray
  • C. R. Bard
  • Elekta
  • IBA Worldwide
  • Varian Medical Systems
  • Carl Zeiss Meditec
  • iCAD
  • IsoRay
  • Mevion Medical Systems
  • Nordion
  • NTP Radioisotopes
  • Canon Medical Systems

Global Radiation Oncology market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Radiation Oncology market, Segment by Type:

  • External Beam Radiation Therapy (EBRT)
  • Brachytherapy

Global Radiation Oncology market, by Application

  • Blood Cancer (Leukaemia)
  • Breast Cancer
  • Gastrointestinal Cancer
  • Respiratory/Lung Cancer
  • Skin Cancer
  • Other Cancers

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Radiation Oncology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Radiation Oncology
1.1 Radiation Oncology Market Overview
1.1.1 Radiation Oncology Product Scope
1.1.2 Radiation Oncology Market Status and Outlook
1.2 Global Radiation Oncology Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Radiation Oncology Market Size by Region (2018-2029)
1.4 Global Radiation Oncology Historic Market Size by Region (2018-2023)
1.5 Global Radiation Oncology Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Radiation Oncology Market Size (2018-2029)
1.6.1 North America Radiation Oncology Market Size (2018-2029)
1.6.2 Europe Radiation Oncology Market Size (2018-2029)
1.6.3 Asia-Pacific Radiation Oncology Market Size (2018-2029)
1.6.4 Latin America Radiation Oncology Market Size (2018-2029)
1.6.5 Middle East & Africa Radiation Oncology Market Size (2018-2029)
2 Radiation Oncology Market by Type
2.1 Introduction
2.1.1 External Beam Radiation Therapy (EBRT)
2.1.2 Brachytherapy
2.2 Global Radiation Oncology Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Radiation Oncology Historic Market Size by Type (2018-2023)
2.2.2 Global Radiation Oncology Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Radiation Oncology Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Radiation Oncology Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Radiation Oncology Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Radiation Oncology Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Radiation Oncology Revenue Breakdown by Type (2018-2029)
3 Radiation Oncology Market Overview by Application
3.1 Introduction
3.1.1 Blood Cancer (Leukaemia)
3.1.2 Breast Cancer
3.1.3 Gastrointestinal Cancer
3.1.4 Respiratory/Lung Cancer
3.1.5 Skin Cancer
3.1.6 Other Cancers
3.2 Global Radiation Oncology Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Radiation Oncology Historic Market Size by Application (2018-2023)
3.2.2 Global Radiation Oncology Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Radiation Oncology Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Radiation Oncology Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Radiation Oncology Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Radiation Oncology Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Radiation Oncology Revenue Breakdown by Application (2018-2029)
4 Radiation Oncology Competition Analysis by Players
4.1 Global Radiation Oncology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiation Oncology as of 2022)
4.3 Date of Key Players Enter into Radiation Oncology Market
4.4 Global Top Players Radiation Oncology Headquarters and Area Served
4.5 Key Players Radiation Oncology Product Solution and Service
4.6 Competitive Status
4.6.1 Radiation Oncology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Accuray
5.1.1 Accuray Profile
5.1.2 Accuray Main Business
5.1.3 Accuray Radiation Oncology Products, Services and Solutions
5.1.4 Accuray Radiation Oncology Revenue (US$ Million) & (2018-2023)
5.1.5 Accuray Recent Developments
5.2 C. R. Bard
5.2.1 C. R. Bard Profile
5.2.2 C. R. Bard Main Business
5.2.3 C. R. Bard Radiation Oncology Products, Services and Solutions
5.2.4 C. R. Bard Radiation Oncology Revenue (US$ Million) & (2018-2023)
5.2.5 C. R. Bard Recent Developments
5.3 Elekta
5.3.1 Elekta Profile
5.3.2 Elekta Main Business
5.3.3 Elekta Radiation Oncology Products, Services and Solutions
5.3.4 Elekta Radiation Oncology Revenue (US$ Million) & (2018-2023)
5.3.5 IBA Worldwide Recent Developments
5.4 IBA Worldwide
5.4.1 IBA Worldwide Profile
5.4.2 IBA Worldwide Main Business
5.4.3 IBA Worldwide Radiation Oncology Products, Services and Solutions
5.4.4 IBA Worldwide Radiation Oncology Revenue (US$ Million) & (2018-2023)
5.4.5 IBA Worldwide Recent Developments
5.5 Varian Medical Systems
5.5.1 Varian Medical Systems Profile
5.5.2 Varian Medical Systems Main Business
5.5.3 Varian Medical Systems Radiation Oncology Products, Services and Solutions
5.5.4 Varian Medical Systems Radiation Oncology Revenue (US$ Million) & (2018-2023)
5.5.5 Varian Medical Systems Recent Developments
5.6 Carl Zeiss Meditec
5.6.1 Carl Zeiss Meditec Profile
5.6.2 Carl Zeiss Meditec Main Business
5.6.3 Carl Zeiss Meditec Radiation Oncology Products, Services and Solutions
5.6.4 Carl Zeiss Meditec Radiation Oncology Revenue (US$ Million) & (2018-2023)
5.6.5 Carl Zeiss Meditec Recent Developments
5.7 iCAD
5.7.1 iCAD Profile
5.7.2 iCAD Main Business
5.7.3 iCAD Radiation Oncology Products, Services and Solutions
5.7.4 iCAD Radiation Oncology Revenue (US$ Million) & (2018-2023)
5.7.5 iCAD Recent Developments
5.8 IsoRay
5.8.1 IsoRay Profile
5.8.2 IsoRay Main Business
5.8.3 IsoRay Radiation Oncology Products, Services and Solutions
5.8.4 IsoRay Radiation Oncology Revenue (US$ Million) & (2018-2023)
5.8.5 IsoRay Recent Developments
5.9 Mevion Medical Systems
5.9.1 Mevion Medical Systems Profile
5.9.2 Mevion Medical Systems Main Business
5.9.3 Mevion Medical Systems Radiation Oncology Products, Services and Solutions
5.9.4 Mevion Medical Systems Radiation Oncology Revenue (US$ Million) & (2018-2023)
5.9.5 Mevion Medical Systems Recent Developments
5.10 Nordion
5.10.1 Nordion Profile
5.10.2 Nordion Main Business
5.10.3 Nordion Radiation Oncology Products, Services and Solutions
5.10.4 Nordion Radiation Oncology Revenue (US$ Million) & (2018-2023)
5.10.5 Nordion Recent Developments
5.11 NTP Radioisotopes
5.11.1 NTP Radioisotopes Profile
5.11.2 NTP Radioisotopes Main Business
5.11.3 NTP Radioisotopes Radiation Oncology Products, Services and Solutions
5.11.4 NTP Radioisotopes Radiation Oncology Revenue (US$ Million) & (2018-2023)
5.11.5 NTP Radioisotopes Recent Developments
5.12 Canon Medical Systems
5.12.1 Canon Medical Systems Profile
5.12.2 Canon Medical Systems Main Business
5.12.3 Canon Medical Systems Radiation Oncology Products, Services and Solutions
5.12.4 Canon Medical Systems Radiation Oncology Revenue (US$ Million) & (2018-2023)
5.12.5 Canon Medical Systems Recent Developments
6 North America
6.1 North America Radiation Oncology Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Radiation Oncology Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Radiation Oncology Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Radiation Oncology Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Radiation Oncology Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Radiation Oncology Market Dynamics
11.1 Radiation Oncology Industry Trends
11.2 Radiation Oncology Market Drivers
11.3 Radiation Oncology Market Challenges
11.4 Radiation Oncology Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’